top of page

Galcanezumab Boosts Brain Connectivity in Migraine Relief
A recent study published in Scientific Reports reveals how galcanezumab, a monoclonal antibody for migraine prevention, influences brain connectivity ...

MigraineMind
Dec 11, 20251 min read
Daily Research Roundup: 5 New Migraine Studies
Today's migraine research brings 5 important studies covering breakthrough treatments, new insights, and innovative approaches to migraine management....

MigraineMind
Dec 10, 20251 min read
Link Between CRPS and Migraines: Shared Pathways Explored
A study published in Cephalalgia explores the link between complex regional pain syndrome (CRPS) and migraine, suggesting they may share underlying me...

MigraineMind
Dec 10, 20251 min read
Migraine Insights: Sensory Processing Abnormalities Unveiled
A systematic review published in Cephalalgia delves into evoked potential studies to understand sensory processing abnormalities in migraine patients....

MigraineMind
Dec 10, 20251 min read
Rimegepant: Safe Daily Migraine Prevention, New Study Finds
A recent study published in the Journal of Headache and Pain assessed the safety of daily 75 mg rimegepant for preventing episodic migraines over 24 w...

MigraineMind
Dec 10, 20251 min read
Understanding Placebo Effects in Migraine Prevention Trials
A new study published in The AAPS Journal highlights the complexities of the placebo response in migraine treatment trials. Researchers conducted a me...

MigraineMind
Dec 10, 20251 min read
Triptans and NSAIDs: Key Players in Migraine Management in England
A recent study published in BMC Primary Care explores the use of triptans and other acute migraine treatments in England's routine clinical practice. ...

MigraineMind
Dec 10, 20251 min read
bottom of page